Adequan Signs as Six Figure Title Sponsor of Global Dressage Festival
8 years ago admin Comments Off on Adequan Signs as Six Figure Title Sponsor of Global Dressage Festival
WELLINGTON, Florida, April 17–Adequan, a horse joint treatment product, has signed on to become the title sponsor of the Global Dressage Festival in Wellington, Florida, for the next three years.
Allyn Mann, director of the Animal Health Division of Luitpold, said the company was “really excited to have the opportunity” to sponsor the GDF in an agreement that “is in the six-figure range.”
“When the opportunity presented itself during a visit to Wellington it elevated my excitement to make an impact on that segment of the equestrian industry,” he told dressage-news.com.
“We believe that what they’re doing in Wellington with the quality of the facility and the competition calendar this will become the place to be for the global dressage community in winter. It provides us with the opportunity to reach out to rider, trainers, owners globally.”
The inaugural Global Dressage Festival winter circuit ended last weekend with the first non-championship Nations Cup in the Western Hemisphere. It was the finale of a lineup of five CDIs, including two World Cup events and the only CDI5* in North America in 2012, offering prize money of more than $270,000.
Adequan is a prime sponsor of high performance horse sports in the United States, including a CSI at the Winter Equestrian Festival, the North American Junior/Young Rider Championships as well as the U.S. Dressage Federation’s year-end awards, hunter-jumper competitions and reining.
The sponsorship agreement with Equestrian Sport Productions, the management company for the Global Dressage Festival at the Palm Beach International Equestrian Center, is for 2013 through the 2015 show season.
Luitpold Animal Health’s Adequan® i.m. (Polysulfated Glycosaminoglycan) is the only Food and Drug Administration-approved disease modifying osteoarthritis drug for horses. Adequan i.m. helps repair damaged joints and stop degenerative joint disease.